Similar articles

• Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.

  Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N. Chiantera V, et al. Menopause. 2003 Jul-Aug;10(4):286-91. doi: 10.1097/01.GME.0000054762.94658.B4. Menopause. 2003. PMID: 12851511 Clinical Trial.
• Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women.

  Smolders RG, de Meer K, Kenemans P, Teerlink T, Jakobs C, van der Mooren MJ. Smolders RG, et al. Eur J Obstet Gynecol Reprod Biol. 2004 Nov 10;117(1):55-9. doi: 10.1016/j.ejogrb.2003.10.033. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15474245 Clinical Trial.
• Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.

  Mijatovic V, Kenemans P, Netelenbos C, Jakobs C, Popp-Snijders C, Peters-Muller ER, van der Mooren MJ. Mijatovic V, et al. Fertil Steril. 1998 May;69(5):876-82. doi: 10.1016/s0015-0282(98)00041-7. Fertil Steril. 1998. PMID: 9591496 Clinical Trial.
• Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.

  L'hermite M, Simoncini T, Fuller S, Genazzani AR. L'hermite M, et al. Maturitas. 2008 Jul-Aug;60(3-4):185-201. doi: 10.1016/j.maturitas.2008.07.007. Epub 2008 Sep 5. Maturitas. 2008. PMID: 18775609 Review.
• New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.

  Sitruk-Ware R. Sitruk-Ware R. Climacteric. 2007 Oct;10(5):358-70. doi: 10.1080/13697130701609121. Climacteric. 2007. PMID: 17852138 Review.